FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3142861708> ?p ?o ?g. }

• W3142861708 endingPage "e0249728" @default.
• W3142861708 startingPage "e0249728" @default.
• W3142861708 abstract "Aim Osteoporotic fractures negatively impact health-related quality of life and prognosis. Advanced glycation end products (AGEs) impair bone quality and reduce bone strength. The aim of this study was to determine the relationship between plasma levels of pentosidine, a surrogate marker for AGEs, and prevalent fractures in patients with chronic liver disease (CLD). Methods This cross-sectional study included 324 patients with CLD. Vertebral fractures were evaluated using lateral thoracolumbar spine radiographs. Information on prevalent fractures was obtained through a medical interview, medical records, and/or radiography. The patients were classified into low (L), intermediate (I), and high (H) pentosidine (Pen) groups based on baseline plasma pentosidine levels. Results Of the 324 patients, 105 (32.4%) had prevalent fractures. The prevalence of liver cirrhosis (LC) and prevalent fractures significantly increased stepwise with elevated pentosidine levels. The H-Pen group had the highest prevalence of LC (88.6%, p < 0.001) and prevalent fractures (44.3%, p = 0.007), whereas the L-Pen group had the lowest prevalence of LC (32.1%, p < 0.001) and prevalent fractures (21.0%, p = 0.007). Multiple logistic regression analysis identified pentosidine as a significant independent factor related to prevalent fractures (odds ratio = 1.069, p < 0.001). Pentosidine levels increased stepwise and correlated with liver disease severity. They were markedly high in patients with decompensated LC. In multiple regression analysis, liver functional reserve factors (total bilirubin, albumin, and prothrombin time-international normalized ratio) significantly and independently correlated with pentosidine levels. Conclusions Plasma pentosidine was significantly associated with prevalent fractures and liver functional reserve in patients with CLD. Pentosidine may be useful in predicting fracture risk and should be closely followed in CLD patients with advanced disease." @default.
• W3142861708 created "2021-04-13" @default.
• W3142861708 creator A5013680271 @default.
• W3142861708 creator A5021836764 @default.
• W3142861708 creator A5037009685 @default.
• W3142861708 creator A5041315244 @default.
• W3142861708 creator A5054899877 @default.
• W3142861708 creator A5073179566 @default.
• W3142861708 creator A5073793600 @default.
• W3142861708 creator A5086743926 @default.
• W3142861708 date "2021-04-02" @default.
• W3142861708 modified "2023-10-15" @default.
• W3142861708 title "Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease" @default.
• W3142861708 cites W1962242957 @default.
• W3142861708 cites W1964129973 @default.
• W3142861708 cites W1972474058 @default.
• W3142861708 cites W1987373195 @default.
• W3142861708 cites W1988102983 @default.
• W3142861708 cites W2014092961 @default.
• W3142861708 cites W2025547729 @default.
• W3142861708 cites W2030389395 @default.
• W3142861708 cites W2037277643 @default.
• W3142861708 cites W2068394273 @default.
• W3142861708 cites W2081616113 @default.
• W3142861708 cites W2082466238 @default.
• W3142861708 cites W2085314827 @default.
• W3142861708 cites W2088588903 @default.
• W3142861708 cites W2124748818 @default.
• W3142861708 cites W2136966666 @default.
• W3142861708 cites W2142920519 @default.
• W3142861708 cites W2152575748 @default.
• W3142861708 cites W2153059487 @default.
• W3142861708 cites W2529327478 @default.
• W3142861708 cites W2578580786 @default.
• W3142861708 cites W2773308676 @default.
• W3142861708 cites W2784039673 @default.
• W3142861708 cites W2793003294 @default.
• W3142861708 cites W2805419319 @default.
• W3142861708 cites W2885410343 @default.
• W3142861708 cites W2888658265 @default.
• W3142861708 cites W2951871544 @default.
• W3142861708 cites W2970060369 @default.
• W3142861708 cites W2997861452 @default.
• W3142861708 cites W3044780385 @default.
• W3142861708 cites W4229508150 @default.
• W3142861708 cites W3083471093 @default.
• W3142861708 doi "https://doi.org/10.1371/journal.pone.0249728" @default.
• W3142861708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8018620" @default.
• W3142861708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33798236" @default.
• W3142861708 hasPublicationYear "2021" @default.
• W3142861708 type Work @default.
• W3142861708 sameAs 3142861708 @default.
• W3142861708 citedByCount "7" @default.
• W3142861708 countsByYear W31428617082021 @default.
• W3142861708 countsByYear W31428617082022 @default.
• W3142861708 countsByYear W31428617082023 @default.
• W3142861708 crossrefType "journal-article" @default.
• W3142861708 hasAuthorship W3142861708A5013680271 @default.
• W3142861708 hasAuthorship W3142861708A5021836764 @default.
• W3142861708 hasAuthorship W3142861708A5037009685 @default.
• W3142861708 hasAuthorship W3142861708A5041315244 @default.
• W3142861708 hasAuthorship W3142861708A5054899877 @default.
• W3142861708 hasAuthorship W3142861708A5073179566 @default.
• W3142861708 hasAuthorship W3142861708A5073793600 @default.
• W3142861708 hasAuthorship W3142861708A5086743926 @default.
• W3142861708 hasBestOaLocation W31428617081 @default.
• W3142861708 hasConcept C126322002 @default.
• W3142861708 hasConcept C141071460 @default.
• W3142861708 hasConcept C147990577 @default.
• W3142861708 hasConcept C156957248 @default.
• W3142861708 hasConcept C170493617 @default.
• W3142861708 hasConcept C2777075537 @default.
• W3142861708 hasConcept C2777214474 @default.
• W3142861708 hasConcept C2779102576 @default.
• W3142861708 hasConcept C2780758796 @default.
• W3142861708 hasConcept C71924100 @default.
• W3142861708 hasConcept C90924648 @default.
• W3142861708 hasConceptScore W3142861708C126322002 @default.
• W3142861708 hasConceptScore W3142861708C141071460 @default.
• W3142861708 hasConceptScore W3142861708C147990577 @default.
• W3142861708 hasConceptScore W3142861708C156957248 @default.
• W3142861708 hasConceptScore W3142861708C170493617 @default.
• W3142861708 hasConceptScore W3142861708C2777075537 @default.
• W3142861708 hasConceptScore W3142861708C2777214474 @default.
• W3142861708 hasConceptScore W3142861708C2779102576 @default.
• W3142861708 hasConceptScore W3142861708C2780758796 @default.
• W3142861708 hasConceptScore W3142861708C71924100 @default.
• W3142861708 hasConceptScore W3142861708C90924648 @default.
• W3142861708 hasIssue "4" @default.
• W3142861708 hasLocation W31428617081 @default.
• W3142861708 hasLocation W31428617082 @default.
• W3142861708 hasLocation W31428617083 @default.
• W3142861708 hasOpenAccess W3142861708 @default.
• W3142861708 hasPrimaryLocation W31428617081 @default.
• W3142861708 hasRelatedWork W2037300217 @default.
• W3142861708 hasRelatedWork W2041427500 @default.
• W3142861708 hasRelatedWork W2172263024 @default.
• W3142861708 hasRelatedWork W2389159997 @default.

• next